Untreated gleason grade progression on serial biopsies during prostate cancer active surveillance: Clinical course and pathological outcomes

Journal of Urology

Volumn 194, Issue 1, 2015, Pages 85-90

  Hussein, A A ^a,b   Welty, C J ^a   Ameli, N ^a   Cowan, J E ^a   Leapman, M ^a   Porten, S P ^a   Shinohara, K ^a   Carroll, P R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

disease progression; neoplasm grading; prostatic neoplasms; watchful waiting

Indexed keywords

ANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVERSE OUTCOME; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; CRYOTHERAPY; DIGITAL RECTAL EXAMINATION; DISEASE COURSE; DISEASE SURVEILLANCE; FOLLOW UP; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE VOLUME; RETROSPECTIVE STUDY; SURVIVAL RATE; THERAPY DELAY; TIME TO TREATMENT; TUMOR VOLUME; BIOPSY; CANCER GRADING; MIDDLE AGED; PATHOLOGY; PROSTATE; PROSTATIC NEOPLASMS; VERY ELDERLY; WATCHFUL WAITING;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; DISEASE PROGRESSION; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; WATCHFUL WAITING;

EID: 84940659041     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2015.01.077     Document Type: Article

References (22)

1. F. Bray, J. Lortet-Tieulent, J. Ferlay, and et al. Prostate cancer incidence and mortality trends in 37 European countries: an overview Eur J Cancer 46 2010 3040
2. J. Hugosson, S. Carlsson, G. Aus, and et al. Mortality results from the Goteborg randomised population-based prostate-cancer screening trial Lancet Oncol 11 2010 725
3. J.L. Mohler, P.W. Kantoff, A.J. Armstrong, and et al. Prostate cancer, version 2.2014 J Natl Compr Canc Netw 12 2014 686
4. H.B. Carter, P.C. Albertsen, M.J. Barry, and et al. Early detection of prostate cancer: AUA guideline J Urol 190 2013 419
5. T.B. Sheridan, H.B. Carter, W. Wang, and et al. Change in prostate cancer grade over time in men followed expectantly for stage T1c disease J Urol 179 2008 901
6. L. Klotz, L. Zhang, A. Lam, and et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126
7. L. Klotz Active surveillance for favorable-risk prostate cancer: background, patient selection, triggers for intervention, and outcomes Curr Urol Rep 13 2012 153
8. H.B. Carter, P.C. Walsh, P. Landis, and et al. Expectant management of nonpalpable prostate cancer with curative intent: preliminary results J Urol 167 2002 1231
9. J.I. Epstein, P.C. Walsh, M. Carmichael, and et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368
10. L. Cheng, C.K. Poulos, C.X. Pan, and et al. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens J Urol 174 2005 898
11. M.R. Cooperberg, J.E. Cowan, J.F. Hilton, and et al. Outcomes of active surveillance for men with intermediate-risk prostate cancer J Clin Oncol 29 2011 228
12. K.C. Cary, J.E. Cowan, M. Sanford, and et al. Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies Eur Urol 66 2014 337
13. N.M. Corcoran, C.M. Hovens, M.K. Hong, and et al. Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumours BJU Int 109 2012 660
14. P. Emiliozzi, S. Maymone, A. Paterno, and et al. Increased accuracy of biopsy Gleason score obtained by extended needle biopsy J Urol 172 2004 2224
15. S.Y. Wang, J.E. Cowan, K.C. Cary, and et al. Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer BJU Int 114 2014 E18
16. S.J. Freedland, C.J. Kane, C.L. Amling, and et al. Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications Urology 69 2007 495
17. F. Dong, J.S. Jones, A.J. Stephenson, and et al. Prostate cancer volume at biopsy predicts clinically significant upgrading J Urol 179 2008 896
18. R.C. van den Bergh, E.W. Steyerberg, A. Khatami, and et al. Is delayed radical prostatectomy in men with low-risk screen-detected prostate cancer associated with a higher risk of unfavorable outcomes? Cancer 116 2010 1281
19. V.R. Patel, R.F. Coelho, B. Rocco, and et al. Positive surgical margins after robotic assisted radical prostatectomy: a multi-institutional study J Urol 186 2011 511
20. V. Iremashvili, J. Burdick-Will, and M.S. Soloway Improving risk stratification in patients with prostate cancer managed by active surveillance: a nomogram predicting the risk of biopsy progression BJU Int 112 2013 39
21. R.C. van den Bergh, H.U. Ahmed, C.H. Bangma, and et al. Novel tools to improve patient selection and monitoring on active surveillance for low-risk prostate cancer: a systematic review Eur Urol 65 2014 1023
22. M.C. Haffner, A.M. De Marzo, S. Yegnasubramanian, and et al. Diagnostic challenges of clonal heterogeneity in prostate cancer J Clin Oncol 33 2015 e38